The health system returned $156 million of the $338 million it received.
Mayo said it was able to return the funding, made through the Coronavirus, Aid, Relief and Economic Security Act, due to its earlier-than-expected financial recovery.
Mayo said it hopes the “funds can be redistributed to organizations with immediate needs.”
“Mayo Clinic is grateful for the federal CARES provider relief funding, which was critical to supporting Mayo’s response to the COVID-19 pandemic,” a statement from Mayo Clinic said. “We understand the responsibility that comes with accepting this funding, which was intended to support organizations facing losses resulting from COVID-19. Thanks to the hard work of Mayo Clinic staff and the strong partnerships within the communities we serve, we have been able to resume many of our practice, research and education activities.”
More articles on healthcare finance:
Chicago’s Mercy Hospital can’t close, Illinois regulators say
Congress agrees on $900B COVID-19 relief package, $1.4 trillion funding deal: 7 things to know
‘There are bound to be loopholes’: Americans may face unexpected bills with COVID-19 vaccination
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
